Socio-economic determinants of early discontinuation of anti-depressant treatment in young adults

European Journal of Public Health

Volumn 23, Issue 3, 2013, Pages 433-440

  Sundell, Karolina Andersson ^a   Waern, Margda ^b   Petzold, Max ^a   Gissler, Mika ^a,c  

^a NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; DRUG UTILIZATION; EDUCATIONAL STATUS; FEMALE; HUMAN; MALE; MENTAL DISORDERS; MIGRANT; PATIENT COMPLIANCE; PSYCHOLOGY; REGRESSION ANALYSIS; RISK; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SWEDEN; TIME; TREATMENT REFUSAL; YOUNG ADULT;

ADULT; ANTIDEPRESSIVE AGENTS; DRUG UTILIZATION; EDUCATIONAL STATUS; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MENTAL DISORDERS; ODDS RATIO; PATIENT COMPLIANCE; REGRESSION ANALYSIS; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; SOCIOECONOMIC FACTORS; SWEDEN; TIME FACTORS; TREATMENT REFUSAL; YOUNG ADULT;

EID: 84878302182     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckr137     Document Type: Article

References (30)

1. Gardarsdottir H, Heerdink ER, van Dijk L, Egberts AC. Indications for antidepressant drug prescribing in general practice in the Netherlands. J Affect Disord 2007;98:109-15.
2. Sihvo S, Isometsa E, Kiviruusu O, et al. Antidepressant utilisation patterns and determinants of short-term and non-psychiatric use in the Finnish general adult population. J Affect Disord 2008;110:94-105.
3. The Swedish Council on Technology Assessment in Health Care. Behandling av depressionssjukdomar. En systematisk litteraturöversikt Treatment of depression. Stockholm; 2004.
4. van Geffen EC, Gardarsdottir H, van Hulten R, et al. Initiation of antidepressant therapy: do patients follow the GP's prescription? Br J Gen Pract 2009;59:81-7.
5. van Geffen EC, van Hulten R, Bouvy ML, et al. Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment. Ann Pharmacother 2008;42:218-25.
6. Rosholm JU, Andersen M, Gram LF. Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants?. A prescription database study. Eur J Clin Pharmacol 2001;56:923-9.
7. Rosholm JU, Gram LF, Isacsson G, et al. Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: a prescription database study. Eur J Clin Pharmacol 1997;52:205-9.
8. Gardarsdottir H, Egberts AC, van Dijk L, et al. An algorithm to identify antidepressant users with a diagnosis of depression from prescription data. Pharmacoepidemiol Drug Saf 2009;18:7-15.
9. Gardarsdottir H, van Geffen EC, Stolker JJ, et al. Does the length of the first antidepressant treatment episode influence risk and time to a second episode? J Clin Psychopharmacol 2009;29:69-72.
10. Gardarsdottir H, Egberts TC, van Dijk L, Heerdink ER. Seasonal patterns of initiating antidepressant therapy in general practice in the Netherlands during 2002-2007. J Affect Disord 2010;122:208-12.
11. Percudani M, Barbui C, Fortino I, Petrovich L. Antidepressant drug use in Lombardy, Italy: a population-based study. J Affect Disord 2004;83:169-75.
12. Hansen DG, Vach W, Rosholm JU, et al. Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Fam Pract 2004;21:623-9.
13. Isacsson G, Boethius G, Henriksson S, et al. Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. J Affect Disord 1999;53:15-22.
14. Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 2006;163:101-8.
15. Vanelli M, Coca-Perraillon M. Role of patient experience in antidepressant adherence: a retrospective data analysis. Clin Ther 2008;30:1737-45.
16. Mancini J, Thirion X, Masut A, et al. Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002. Pharmacoepidemiol Drug Saf 2006;15:494-503.
17. Murray ML, de Vries CS, Wong IC. A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child 2004;89:1098-102.
18. Lawrenson RA, Tyrer F, Newson RB, Farmer RD. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affect Disord 2000;59:149-57.
19. Meijer WE, Heerdink ER, Leufkens HG, et al. Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 2004;60:57-61.
20. Gardarsdottir H, Egberts TC, Stolker JJ, Heerdink ER. Duration of antidepressant drug treatment and its influence on risk of relapse/recurrence: immortal and neglected time bias. Am J Epidemiol 2009;170:280-5.
21. Andersson L. Regional Differences in Disability Pension and Sickness Absence with Psychiatric Diagnoses in Sweden and Norway 1980-2000: The Influence of Demography and Access to Psychiatric Health Care. Göteborg: The Sahlgrenska Academy at Göteborg University, Department of Public Health and Community Medicine, 2006.
22. Arnett JJ. Emerging adulthood: what is it, and what is it good For? Child Dev Persp 2007;1:68-73.
23. Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007;16:726-35.
24. WHO Collaborating Centre for Drug Statistics Methodology. ATC Classification Index with DDDs, 2010, Oslo; 2009.
25. Act (2002:160) on Pharmaceutical Benefits, etc. 2002 11 April 2002.
26. Andersson Sundell K, Gissler M, Petzold M, Waern M. Antidepressant utilization patterns and mortality in Swedish men and women aged 20-34 years. Eur J Clin Pharmacol 2011;67:169-78.
27. Hansen DG, Sondergaard J, Vach W, et al. Socio-economic inequalities in first-time use of antidepressants: a population-based study. Eur J Clin Pharmacol 2004;60: 51-5.
28. Jorm AF, Christensen H, Griffiths KM. Belief in the harmfulness of antidepressants: results from a national survey of the Australian public. J Affect Disord 2005;88: 47-53.
29. Milea D, Guelfucci F, Bent-Ennakhil N, Toumi M, Auray JP. Antidepressant monotherapy: a claims database analysis of treatment changes and treatment duration. Clin Ther 2010;32:2057-72.
30. National Board of Health and Welfare. Statistics on In-patient Care. 2010; Available at: http://www.socialstyrelsen.se/statistik/statistikefteramne/ slutenvarddiagnosstatistikiexcel (3 July 2011, date last accessed).